The SCCS published the Scientific Advice on the safety of nanomaterials in cosmetics, shedding some light on this rather obscure aspect of the cosmetic industry.

The SCCS published the Scientific Advice on the safety of nanomaterials in cosmetics, shedding some light on this rather obscure aspect of the cosmetic industry.
As of May 1, 2021, notification of the insertion and removal of implantable devices will become mandatory in Belgium for stents, mechanical cardiac and ophthalmological implants, and some other implants
The EU Chemical Strategy for Sustainability aims to build a zero-pollution environment in line with Europe’s new agreement towards a toxic-free Union: The Green Deal.
In September 2020, a guidance was issued on the use of the UKCA mark from January 1, 2021, as a substitute for the CE mark on the UK market.
Regulatory Framework & National Registrations information for manufacturers who want to place their products in the EU market.
Cannabis and its related components pose specific challenges to compliance with the Cosmetics Regulation 1223/2009/EC, main regulatory framework for cosmetics
With Cosmetic Regulation 1223/2009, Europe proclaimed a total ban on animal testing for cosmetic products and their ingredients to avoid any animal suffering for cosmetic reasons.
The Italian Ministry of Health published first report on the surveillance activity it carries out on medical devices to ensure only safe and effective devices are circulating on the national territory.
The Kanavape Case (C-663/18) judgment provides some much-needed clarity over the status of CBD in the EU and whether it should be classified as a narcotic substance.
It is crucial to remember the importance of Regulation (EU) No 655/2013, regulating the common criteria for the justification of claims on cosmetic products.